Related references
Note: Only part of the references are listed.Repurposing an atherosclerosis targeting peptide for tumor imaging
Luciana Kovacs et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Perspectives for a new drug candidate for Chagas disease therapy
Maria de Nazare Correia Soeiro
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2022)
Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi
Julianna Siciliano de Araujo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In Vitro and In Vivo Evaluation of an Adamantyl-Based Phenyl Sulfonyl Acetamide against Cutaneous Leishmaniasis Models of Leishmania amazonensis
Camila C. Santos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi
M. R. Simoes-Silva et al.
PARASITOLOGY (2019)
Chagas Disease: From Discovery to a Worldwide Health Problem
Karita Claudia Freitas Lidani et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Imidazole Derivatives as Promising Agents for the Treatment of Chagas Disease
Juliann Siciliano de Araujo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration
Ludmila Ferreira de Almeida Fiuza et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Current advances in drug discovery for Chagas disease
Caue Benito Scarim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Macrophage plasticity, polarization, and function in health and disease
Abbas Shapouri-Moghaddam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
An autopsy-based study of Trypanosoma cruzi persistence in organs of chronic chagasic patients and its relevance for transplantation
Luiz A. Benvenuti et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Chagas disease research and development: Is there light at the end of the tunnel?
Eric Chatelain
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2017)
Experimental and Clinical Treatment of Chagas Disease: A Review
Policarpo Ademar Sales Junior et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi
F. H. Guedes-da-Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17
Steffen Riethmueller et al.
SCIENTIFIC REPORTS (2016)
CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis
Rosemeire A. Silva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Different Therapeutic Outcomes of Benznidazole and VNI Treatments in Different Genders in Mouse Experimental Models of Trypanosoma cruzi Infection
F. H. Guedes-da-Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In Vitro and In Vivo Biological Effects of Novel Arylimidamide Derivatives against Trypanosoma cruzi
Bruno Lisboa Timm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages
Anders Etzerodt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment
Denise da Gama Jaen Batista et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria
Babs O. Fabriek et al.
BLOOD (2009)
Trypanosoma cruzi targets for new chemotherapeutic approaches
Maria Nazare C. Soeiro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Share Paper
